The Jan. 5 White House graphic showed two babies, each surrounded by needles, with the text: "European Country: 11 injections ...
Under the 2024 schedule, which has been discontinued, babies could have received anywhere from 12 to 30 shots before their second birthday ...
Clesrovimab is a long-acting investigational monoclonal antibody against site IV of the respiratory syncytial virus (RSV) fusion protein. Data regarding the safety and efficacy of clesrovimab in ...